eResearch Technology, Inc  

(Public, NASDAQ:ERT)   Watch this stock  
Find more results for ERTS
- Close
NASDAQ real-time data - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 394.13M
P/E 0.00
Div/yield     -
EPS 0.29
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 7.43% 7.42%
Operating margin 12.55% 10.55%
EBITD margin - 25.28%
Return on average assets 6.21% 6.03%
Return on average equity 8.66% 8.57%
Employees 663 -
CDP Score - -


1818 Market St. Suite 1000
United States - Map
+1-215-9720420 (Phone)
+1-215-9720414 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


eResearchTechnology, Inc. (eRT) provides technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently. The Company offers centralized electrocardiographic (ECG) services (Cardiac Safety services or EXPeRT ECG services), which are used by pharmaceutical companies, biotechnology companies, medical device companies, clinical trial sponsors and clinical research organizations (CROs) during the conduct of clinical trials. It also offers site support, which includes the rental and sale of cardiac safety equipment along with related supplies and freight. Additionally, the Company offers licensing and, at the client�s option, hosting of its EXPeRT eClinical software products and the provision of maintenance and consulting services in support of these products. In July 2012, Genstar Capital, LLC acquired the Company.